#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cytomegalovirus infection Primary myelofibrosis Dedifferentiated liposarcoma Small for dates baby Bronchiolitis Restless legs syndrome Glomerulonephritis Acute myeloid leukaemia recurrent Sickle cell disease Microvillous inclusion disease Paget's disease of the vulva Precursor T-lymphoblastic lymphoma/leukaemia recurrent Chronic lymphocytic leukaemia Pyruvate dehydrogenase complex deficiency Brain stem glioma More trials…

    Learn about Rare Diseases

    Fabry’s disease – Basic Information Niemann-Pick disease – Trials in Disease Haemophilia – Basic Information Angiosarcoma Brain stem glioma – Trials in Disease Atypical haemolytic uraemic syndrome – Diagnostics Hairy cell leukaemia – Life with Disease Uterine leiomyosarcoma Lymphangiosarcoma – Life with Disease Basal cell naevus syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Moxifloxacin Phenylbutyrate Triamcinolone Ag13909 Spartalizumab Nizaracianine Triflutate Sorafenib Tosilate ALE.P03 Poa Pratensis Timrepigene Emparvovec Cd7-Cart01 Human Albumin Solution Sym024 Macitentan Fipaxalparant Ezabenlimab Diclofenac Epolamine DCC-3084 Zinc Sulphate Heptahydrate Cpft Trifluoroacetate More therapies…

    Learn about Your Condition

    Rasmussen encephalitis Mesothelioma malignant Delayed graft function Alcoholic liver disease Phaeochromocytoma Osteoarthritis Congenital myopathy Pain Adenocarcinoma gastric Uveal melanoma Mastocytosis Astrocytoma malignant Retroperitoneal fibrosis Follicular thyroid cancer Deafness neurosensory More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study to evaluate the safety and tolerability of azathioprine in patients with autosomal dominant polycystic kidney and liver disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Congenital cystic kidney disease
    Investigated Drugs:
    • Azathioprine
    Belgium

  • A study to evaluate the effect of topical clobetasol propionate versus a placebo for the treatment of inflammatory hand osteoarthritis in adults.

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Clobetasol Propionate
    France

  • Study evaluating the effects of palopegteriparatide and alfacalcidol on quality of life and brain function in patients with hypoparathyroidism

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypoparathyroidism
    Investigated Drugs:
    • Alfacalcidol
    • Palopegteriparatide
    Denmark

  • A study comparing the effects of estetrol and drospirenone, ethinylestradiol and drospirenone, and drospirenone in women with polycystic ovary syndrome (PCOS)

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • DROSPIRENONE
    • Ethinylestradiol
    Finland

  • Study of ketamine hydrochloride to improve recovery in adults requiring unplanned mechanical ventilation in the intensive care unit

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Mechanical ventilation
    Investigated Drugs:
    • Ketamine Hydrochloride
    • Sodium Chloride
    France

  • Study of the safety and effectiveness of tolDC therapy in patients with progressive forms of multiple sclerosis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Toldc
    Belgium Spain
Previous Page
1 … 720 721 722 723 724 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!